Original news and analysis on international IP policy
"Emerging Markets and the World Patent Order" is a new book that looks at patent system implementation in emerging market and developing countries, and the response to this implementation by Europe and the United States. Florida State University Law Prof. Frederick Abbott, one of the organisers and editors of the book, recently discussed the book with Intellectual Property Watch
As the World Health Assembly, a new partnership has been launched by three major public health actors in the field of HIV treatment. The initiative is meant to find improved treatments for children suffering from HIV/AIDs. Although all actors agree that significant progress has been made on adult treatments, children-specific medicines are still lacking.
An investment policy review undertaken by the United Nations Conference on Trade and Development (UNCTAD) found that Bangladesh needs to attract foreign direct investment to sustain its development and suggests that the country loosen its grip on the pharmaceutical sector. Bangladesh said the review will be carefully considered.
The recently published book “Chinese Intellectual Property and Technology Laws” provides the “first” overview of Chinese IP and technology law, supported by extensive legal, historical and socioeconomic background to developments in these areas.
The Global Fund to Fight AIDS, Tuberculosis and Malaria has launched an initiative with other agencies aimed at expanding global access to health products such as medicines. But the Fund has had some explaining to do about the initiative, which some say could encompass a plan to allow different prices based on national income levels.
The Medicines Patent Pool (MPP) this week announced two new licencing agreements with the private sector joint venture ViiV Healthcare that will increase access to a new antiretroviral in countries hardest hit by HIV.
Mike Palmedo at Infojustice.org writes: "The U.S. International Trade Commission (ITC) is currently investigating “Indian industrial policies that discriminate against U.S. imports… and the effect those barriers have on the U.S. economy and U.S. jobs.” The investigation was requested by Sen. Hatch, Sen. Baucus, Rep. Camp, and Rep. Levin, and the final report is due to be released in November. Last week it held a series of hearings, where it heard from U.S. business, Indian business, and civil society representatives."
The Quaker UN Office in Geneva has announced two new publications on intellectual property, agriculture, food and biological diversity.
DG Shah writes: Acquisition of brownfield, or existing, pharmaceutical companies may be seen in different perspectives as greenfield, or new, projects are permitted 100% equity via the automatic route. India has sought FDI mainly to bridge the shortfall in investment or to facilitate the flow of know-how and technology. We must first assess the need of the pharma sector and then evaluate whether mere change of ownership would meet its needs.
Participants at a recent conference in South Africa offered insights and some optimism about prospects for local communities to exploit their traditional knowledge to help their economies while at the same time protecting that knowledge.